Depatureaux, Agnès <br/><br/>
Raltegravir-based regimens are effective in HIV-1 group O-infected patients.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Sep 2012 
 - e1-3 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e31826327c4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--methods<br/>CD4 Lymphocyte Count<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV-1--classification<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrrolidinones--administration & dosage<br/>Raltegravir Potassium<br/>Treatment Outcome<br/>Viral Load